• $122,022.00
    Market Cap
  • 900.00%
    1-Year Change
  • Medical Devices
    Industry

Key Performance

More
  • Earnings Score: N/A
  • Momentum Score: 77
  • True Yield: N/A
  • Financial Health Score: N/A
TradeSmith Loading

Latest Research & News

No data found

No data found

Peers

Statistics

More
Day Range
$0.001
$0.001
$0.001
1-Year Range
$0.0001
$0.001
$0.001
Latest Close$0.001
Change
$0.00 (0.00%)
Volume74,715
Market Cap$122,022.00
Shares Outstanding122.0M
P/E (TTM)-0.03
Diluted EPS (TTM)-$0.04
Enterprise Value$248,784.00

Information as of 06/02/2026

Company Profile

Rafina Innovations Inc.
https://rafina-innovations.com
$122,022.00
Market Cap
-$621,583.00
Net Income
Sector: Healthcare
Industry: Medical Devices
Kintyre House, Glasgow, United Kingdom, G51 1HJ
44 1413 700 321

Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.

Key Executives

  • Paraskevi Pilarinou
  • Georgios Thrapsaniotis
  • Nikolaos Kardaras
  • Evaggelia Moschidou
  • Paraskevi Pylarinou

Current Ownership Distribution

  • Insiders177.8M (100.00%)
  • Institutions0 (0.00%)
  • Mutual Funds0 (0.00%)
  • Other0 (0.00%)